Replies to post #224 on BiondVax Pharmaceuticals Ltd (BVXV)

[TechKim]

The safety trial will not meet the life expectancy of the end product. So in other words I do not know what would be the FDA's disapproval cause. I would imagine a stage 4 trial, as a condition of approval.